Evaluation of BrainTagger cognitive games reveals trends in cognitive performance across age stages, indicating potential implications for healthcare.
After reviewing cognitive safety in healthcare, effectiveness of BrainTagger cognitive assessment games in tracking age-related cognitive changes is evaluated. One hundred eighty-three participants, aged 4 to 92, each played up to four games designed to assess cognitive speed, response inhibition, cognitive control, and working memory. Participants were recruited during two public events in Toronto: AGE-TECH Innovation Week (October 24–27, 2023) and the National Home Show (March 8–17, 2024). Piecewise linear regression analyzed game performance across three life stages: development (0–25 years); peak performance (26–50 years); age-related decline (51+ years). All four games demonstrated expected trends, with performance increasing in early years, stabilizing during middle age, and declining after age 50. BrainTagger are shown to track age-related cognitive decline. Future applications in clinical settings may enhance early identification of cognitive harm caused by medical interventions or neglect, contributing to improved cognitive safety in healthcare environments.
No takes yet. Share an insight, caveat, or question.
Chignell et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: